Expertise in
1
conditions

Dr. Mini Elnaggar

Radiation Oncology
CaMc Oncology-Beckley
275 Dry Hill Rd, 
Beckley, WV 
Expertise in
1
conditions
CaMc Oncology-Beckley
275 Dry Hill Rd, 
Beckley, WV 

Overview

Mini Elnaggar is a Radiation Oncologist practicing medicine in Beckley, West Virginia.

Dr. Elnaggar is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Breast Cancer, Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, and Endometrial Cancer.

She is actively involved in clinical research, participating in 5 clinical trials.

Specialties

Radiation Oncology

Licenses

Radiology in IL

Hospital Affiliations

Holy Rosary Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

CaMc Oncology-Beckley
275 Dry Hill Rd, Beckley, WV 25801

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
Enrollment Status: Active_not_recruiting
Publish Date: February 24, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 3
Randomized Phase III Study of Sorafenib Versus Stereotactic Body Radiation Therapy Followed by Sorafenib in Hepatocellular Carcinoma
Randomized Phase III Study of Sorafenib Versus Stereotactic Body Radiation Therapy Followed by Sorafenib in Hepatocellular Carcinoma
Enrollment Status: Completed
Publish Date: January 28, 2026
Intervention Type: Radiation, Drug
Study Drug: Sorafenib Tosylate
Study Phase: Phase 3
A Phase I/II Clinical Study Evaluating the Safety and Effectiveness of BIO 300 Oral Suspension in Patients Receiving Chemoradiation Therapy for Non-Small Cell Lung Cancer (NSCLC)
A Phase I/II Clinical Study Evaluating the Safety and Effectiveness of BIO 300 Oral Suspension in Patients Receiving Chemoradiation Therapy for Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Completed
Publish Date: January 25, 2024
Intervention Type: Drug, Radiation
Study Phase: Phase 1/Phase 2
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: December 27, 2023
Intervention Type: Radiation
Study Phase: Not Applicable
Phase II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery in Combination With Concurrent Lapatinib in Patients With Brain Metastasis From HER2-Positive Breast Cancer - A Collaborative Study of NRG Oncology and KROG
Phase II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery in Combination With Concurrent Lapatinib in Patients With Brain Metastasis From HER2-Positive Breast Cancer - A Collaborative Study of NRG Oncology and KROG
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Other, Radiation, Drug
Study Drug: Lapatinib Ditosylate
Study Phase: Phase 2
View 4 Less Clinical Trials
Similar Doctors
Expertise in
27
conditions
Dr. David Shimm
Radiation Oncology
Expertise in
27
conditions
Dr. David Shimm
Radiation Oncology
Referral may be required

CaMc Oncology-Beckley

275 Dry Hill Rd, 
Beckley, WV 
 (0.1 miles away)
304-253-6060
Languages Spoken:
English
See accepted insurances

David Shimm is a Radiation Oncologist practicing medicine in Beckley, West Virginia. Dr. Shimm is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Astrocytoma, and Embryonal Tumor with Multilayered Rosettes.

Expertise in
16
conditions
Dr. Joseph Baisden
Radiation Oncology
Expertise in
16
conditions
Dr. Joseph Baisden
Radiation Oncology
Referral may be required

Bluefield Regional Medical Center

500 Cherry St, 
Bluefield, WV 
 (37.6 miles away)
304-327-1570
Languages Spoken:
English
See accepted insurances

Joseph Baisden is a Radiation Oncologist practicing medicine in Bluefield, West Virginia. Dr. Baisden is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Laryngeal Cancer, Prostate Cancer, and ALK-Positive Non-Small Cell Lung Cancer.

Expertise in
31
conditions
Dr. Premkumar Raja
Radiation Oncology
Expertise in
31
conditions
Dr. Premkumar Raja
Radiation Oncology
Referral may be required

CAMC Radiation Oncology Services

3415 Maccorkle Ave SE Ste 100, 
Charleston, WV 
 (40.2 miles away)
304-388-1790
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Premkumar Raja is a Radiation Oncologist practicing medicine in Charleston, West Virginia. Dr. Raja is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Laryngeal Cancer, Lung Cancer, and Anal Cancer.

Frequently Asked Questions about Dr. Mini Elnaggar

How do I make an appointment with Dr. Mini Elnaggar?

You can book an appointment with Dr. Mini Elnaggar by calling their office at 304-253-6060. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mini Elnaggar a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mini Elnaggar is classified as an Advanced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mini Elnaggar specialize in?

While Dr. Mini Elnaggar is a Radiation Oncology, they have specific expertise in Breast Cancer, Neuroendocrine Carcinoma of the Cervix, and Cervical Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Mini Elnaggar accept my insurance?

Dr. Mini Elnaggar accepts most major insurance plans, including Blue Cross Blue Shield and Humana. We recommend calling the office directly at 304-253-6060 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Elnaggar's expertise for a condition
ConditionClose
      View All 17 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile